| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
135,385 |
117,592 |
$9.18M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
25,339 |
25,070 |
$5.19M |
| J2785 |
Injection, regadenoson, 0.1 mg |
6,946 |
6,787 |
$2.27M |
| 93015 |
|
13,124 |
12,873 |
$1.90M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
43,168 |
40,434 |
$1.64M |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
10,996 |
10,957 |
$1.44M |
| 99215 |
Prolong outpt/office vis |
10,586 |
10,072 |
$1.43M |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
2,165 |
1,997 |
$795K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
4,784 |
4,760 |
$531K |
| 93880 |
|
2,930 |
2,927 |
$490K |
| 99499 |
|
4,289 |
2,686 |
$478K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
725 |
370 |
$437K |
| 99496 |
|
1,647 |
1,604 |
$386K |
| 93000 |
|
11,527 |
11,336 |
$340K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
8,411 |
3,294 |
$270K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
18,311 |
18,260 |
$267K |
| 90961 |
|
1,481 |
1,459 |
$266K |
| 99205 |
Prolong outpt/office vis |
1,374 |
1,370 |
$265K |
| 95912 |
|
954 |
948 |
$264K |
| 95886 |
|
1,170 |
1,093 |
$170K |
| 95251 |
|
3,713 |
3,469 |
$149K |
| 99223 |
Prolong inpt eval add15 m |
1,978 |
1,941 |
$146K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,900 |
1,892 |
$143K |
| 93224 |
|
1,135 |
1,129 |
$143K |
| 78492 |
|
1,736 |
1,698 |
$134K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
1,512 |
1,367 |
$129K |
| 93458 |
|
690 |
680 |
$113K |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
1,802 |
1,758 |
$87K |
| 90960 |
End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits |
789 |
773 |
$87K |
| 95910 |
|
413 |
411 |
$84K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
637 |
636 |
$80K |
| G9012 |
Other specified case management service not elsewhere classified |
886 |
570 |
$76K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
758 |
684 |
$73K |
| 99495 |
|
395 |
386 |
$70K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
7,955 |
6,940 |
$69K |
| 99385 |
|
591 |
557 |
$69K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
566 |
563 |
$66K |
| 99233 |
Prolong inpt eval add15 m |
1,471 |
644 |
$65K |
| 95819 |
|
742 |
728 |
$63K |
| 93280 |
|
1,278 |
1,229 |
$54K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,125 |
1,035 |
$52K |
| 93297 |
|
3,059 |
3,042 |
$50K |
| 90962 |
|
390 |
387 |
$49K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,079 |
1,066 |
$48K |
| 71045 |
Radiologic examination, chest; single view |
10,687 |
7,262 |
$48K |
| 93295 |
|
1,020 |
1,016 |
$47K |
| 93296 |
|
2,329 |
2,315 |
$46K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
918 |
853 |
$46K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,895 |
6,375 |
$44K |
| 93041 |
|
3,739 |
3,711 |
$43K |
| 75571 |
|
996 |
996 |
$39K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,990 |
2,705 |
$39K |
| 94060 |
|
877 |
867 |
$38K |
| 64615 |
|
322 |
317 |
$37K |
| 99245 |
|
288 |
288 |
$33K |
| 82962 |
|
16,056 |
12,589 |
$33K |
| 10005 |
|
206 |
204 |
$32K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,300 |
3,135 |
$31K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
268 |
163 |
$31K |
| 93283 |
|
443 |
437 |
$31K |
| 90756 |
|
787 |
781 |
$29K |
| 93290 |
|
1,245 |
1,218 |
$28K |
| 94618 |
|
1,178 |
1,092 |
$28K |
| 99386 |
|
253 |
247 |
$27K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,327 |
1,194 |
$27K |
| 36573 |
|
230 |
182 |
$26K |
| 94729 |
|
552 |
549 |
$26K |
| 94726 |
|
547 |
544 |
$26K |
| 99222 |
Initial hospital care, per day, moderate complexity |
435 |
431 |
$25K |
| 95911 |
|
107 |
104 |
$25K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
2,501 |
2,365 |
$25K |
| 93298 |
|
877 |
871 |
$24K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
996 |
976 |
$23K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
820 |
799 |
$23K |
| 95816 |
|
215 |
215 |
$22K |
| 90686 |
|
885 |
819 |
$20K |
| 92551 |
|
1,456 |
1,423 |
$19K |
| 93970 |
|
259 |
252 |
$18K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
282 |
275 |
$17K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,649 |
2,493 |
$17K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
1,242 |
1,238 |
$17K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
841 |
834 |
$17K |
| 93294 |
|
818 |
809 |
$14K |
| 99384 |
|
185 |
180 |
$14K |
| 71250 |
|
366 |
349 |
$13K |
| 81002 |
|
6,369 |
5,408 |
$11K |
| 93228 |
|
398 |
398 |
$10K |
| 90688 |
|
417 |
417 |
$10K |
| 90966 |
|
59 |
55 |
$10K |
| 64505 |
|
104 |
90 |
$9K |
| 20553 |
|
180 |
134 |
$8K |
| 71046 |
Radiologic examination, chest; 2 views |
547 |
491 |
$8K |
| 76536 |
|
125 |
124 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
852 |
788 |
$7K |
| 99173 |
|
1,562 |
1,528 |
$7K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
173 |
172 |
$7K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
187 |
176 |
$7K |
| 0012A |
|
174 |
174 |
$6K |
| 75574 |
|
26 |
26 |
$6K |
| 95250 |
|
35 |
27 |
$6K |
| J0280 |
Injection, aminophyllin, up to 250 mg |
1,166 |
1,103 |
$5K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
231 |
211 |
$5K |
| 95861 |
|
44 |
44 |
$5K |
| 99152 |
|
186 |
176 |
$5K |
| 93312 |
|
29 |
29 |
$5K |
| J1815 |
Injection, insulin, per 5 units |
808 |
631 |
$5K |
| 90714 |
|
124 |
124 |
$4K |
| 0011A |
|
156 |
156 |
$4K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
124 |
48 |
$3K |
| 36005 |
|
36 |
29 |
$3K |
| 76937 |
|
529 |
416 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
34 |
34 |
$3K |
| 93282 |
|
45 |
42 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
27 |
27 |
$3K |
| 93299 |
|
402 |
396 |
$2K |
| 36410 |
|
357 |
297 |
$2K |
| 71270 |
|
12 |
12 |
$2K |
| 94750 |
|
107 |
105 |
$2K |
| 99221 |
|
54 |
53 |
$2K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
351 |
348 |
$2K |
| 93284 |
|
24 |
24 |
$2K |
| 93925 |
|
12 |
12 |
$1K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
178 |
163 |
$1K |
| G9007 |
Coordinated care fee, scheduled team conference |
26 |
26 |
$1K |
| 94200 |
|
264 |
256 |
$1K |
| 90658 |
|
44 |
43 |
$1K |
| 96127 |
|
211 |
208 |
$1K |
| 90674 |
|
32 |
32 |
$1K |
| 93320 |
|
14 |
14 |
$1K |
| 99243 |
|
13 |
13 |
$884.60 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
48 |
45 |
$822.72 |
| 99153 |
Mod sedat endo service >5yrs |
87 |
83 |
$757.64 |
| 3046F |
|
233 |
212 |
$605.06 |
| 93325 |
|
14 |
14 |
$600.26 |
| 94664 |
|
252 |
244 |
$581.12 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
12 |
12 |
$569.66 |
| 93244 |
|
30 |
30 |
$516.53 |
| 36569 |
|
16 |
15 |
$511.93 |
| 74022 |
|
12 |
12 |
$496.68 |
| 80053 |
Comprehensive metabolic panel |
46 |
46 |
$413.55 |
| 84443 |
Thyroid stimulating hormone (TSH) |
30 |
30 |
$413.28 |
| 93242 |
|
31 |
31 |
$394.11 |
| 94010 |
|
14 |
14 |
$383.76 |
| 85018 |
|
236 |
230 |
$383.39 |
| 93307 |
|
26 |
26 |
$322.75 |
| 80061 |
Lipid panel |
26 |
26 |
$288.50 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
16 |
14 |
$277.30 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$256.57 |
| 76775 |
|
13 |
13 |
$255.47 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
514 |
512 |
$252.06 |
| 3044F |
|
278 |
272 |
$194.67 |
| 71010 |
|
28 |
27 |
$183.01 |
| 84480 |
|
14 |
14 |
$163.67 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
74 |
73 |
$158.85 |
| 99490 |
Ccm add 20min |
647 |
647 |
$143.87 |
| 99443 |
|
71 |
71 |
$136.20 |
| 3051F |
|
94 |
93 |
$131.97 |
| 99072 |
|
1,893 |
1,500 |
$130.00 |
| 1036F |
|
2,419 |
2,229 |
$110.60 |
| 3017F |
|
522 |
514 |
$105.56 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
16 |
16 |
$104.61 |
| 84439 |
|
14 |
14 |
$102.83 |
| 76942 |
|
16 |
15 |
$90.64 |
| 1160F |
|
26 |
26 |
$64.81 |
| 1159F |
|
27 |
27 |
$64.74 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
13 |
13 |
$55.07 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
14 |
14 |
$48.09 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
152 |
142 |
$45.98 |
| 1124F |
|
92 |
86 |
$41.27 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
26 |
26 |
$39.41 |
| 1111F |
|
1,017 |
972 |
$38.95 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,229 |
1,191 |
$38.95 |
| 99442 |
|
45 |
45 |
$37.72 |
| 73630 |
|
15 |
14 |
$35.26 |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
26 |
26 |
$33.35 |
| 88738 |
|
520 |
422 |
$24.28 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
1,357 |
1,156 |
$24.24 |
| G0008 |
Administration of influenza virus vaccine |
44 |
43 |
$17.35 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,207 |
1,157 |
$5.35 |
| 1126F |
|
270 |
212 |
$0.00 |
| 3052F |
|
12 |
12 |
$0.00 |
| 3074F |
|
344 |
326 |
$0.00 |
| 99224 |
|
14 |
13 |
$0.00 |
| 3079F |
|
92 |
87 |
$0.00 |
| 1125F |
|
23 |
19 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
15 |
12 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
12 |
12 |
$0.00 |
| 3078F |
|
337 |
317 |
$0.00 |
| 97602 |
|
25 |
20 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
14 |
13 |
$0.00 |
| 3077F |
|
36 |
35 |
$0.00 |
| 4004F |
|
12 |
12 |
$0.00 |